Skip to main content
Clinical Trials/NCT06045390
NCT06045390
Completed
N/A

Assessing the Effects of an In-office, Language-concordant App on Eye Drop Recall in Patients With Multi-drop Regimens

University of California, San Francisco1 site in 1 country20 target enrollmentSeptember 1, 2024
ConditionsGlaucoma

Overview

Phase
N/A
Intervention
Not specified
Conditions
Glaucoma
Sponsor
University of California, San Francisco
Enrollment
20
Locations
1
Primary Endpoint
Percentage accuracy of drop regimen recall
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

The goal of this interventional study is to assess whether an in-office, language-concordant instructional app improves drop regimen recall in a population of glaucoma patients who are on multi-drop regimens.

Participants will be divided into two groups -- those who use the app and those who do not. The app will have narrated information regarding the drop regimen, a quiz to test understanding of the regimen, and will enable a graphical printout of the eye drops and schedule.

At one month, both groups will be assessed on their eye drop regimen recall.

Detailed Description

Specific Aim: To investigate whether a language-concordant instructional application improves drop regimen recall in population of glaucoma patients at a 1-month follow-up period. App features 1. Pictorial representation of drops (color-coded) and schedule. 2. Quiz to assess understanding of the regimen. 3. Narrated instructions (language-concordant) on how and when (frequency and eye laterality) to take each drop. 4. Graphical print-out of the regimen. Study design 1. Study design: Randomized study, two groups: (1) patients that use the app, and (2) patients that do not use the app. 2. Study population: Inclusion criteria: patients with primary open-angle glaucoma on at least 2 eye drops Exclusion criteria: patients taking additional prescribed eye drops for other eye conditions; patients diagnosed within the last 3 months; patients unable to self-administer eye drops 3. Intervention: Use of an in-office app that has both graphical and verbal (language-concordant) instruction for how to use drops. 4. Main outcome measure: Ability to correctly identify drops/regimen

Registry
clinicaltrials.gov
Start Date
September 1, 2024
End Date
June 1, 2025
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patients with a diagnosis of glaucoma (any type)
  • drop regimen of at least 2 pressure-lowering drops
  • languages supported at this time: English, Spanish, Cantonese

Exclusion Criteria

  • concurrent eye conditions necessitating additional eye drops
  • inability to self-administer eye drops
  • inability to engage with app (either visual or other barrier)

Outcomes

Primary Outcomes

Percentage accuracy of drop regimen recall

Time Frame: 1 month follow up from time of intervention

This will be assessed through questions querying which drops the patients are taking, the number of times they are taking each drop, and the laterality of each drop. Each answer/drop will be individual recorded, and then total number of correct answers will be divided by the total number of questions.

Secondary Outcomes

  • Overall medication adherence, assessed through the modified Morisky Adherence Scale, a widely published scale for general medication adherence(1 month follow up from time of intervention)

Study Sites (1)

Loading locations...

Similar Trials

An App-based Instructional Platform to... | Clinical Trial